|
USP51 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60119703554551E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55360169173946E-11 |
| Normal-vs-Stage2 |
4.51360004927182E-09 |
| Normal-vs-Stage3 |
2.461900E-02 |
| Normal-vs-Stage4 |
1.94146999999978E-05 |
| Stage1-vs-Stage2 |
8.695000E-01 |
| Stage1-vs-Stage3 |
2.449600E-02 |
| Stage1-vs-Stage4 |
9.388400E-01 |
| Stage2-vs-Stage3 |
6.076500E-02 |
| Stage2-vs-Stage4 |
8.287000E-01 |
| Stage3-vs-Stage4 |
1.508620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70079506034426E-11 |
| Normal-vs-AfricanAmerican |
5.47510004000884E-09 |
| Normal-vs-Asian |
1.003300E-03 |
| Caucasian-vs-AfricanAmerican |
7.171400E-01 |
| Caucasian-vs-Asian |
9.391400E-01 |
| AfricanAmerican-vs-Asian |
8.473200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44910774888285E-12 |
| Normal-vs-Female |
4.66949999999855E-07 |
| Male-vs-Female |
1.465950E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.420000E-03 |
| Normal-vs-Extreme_Weight |
1.65445435129641E-12 |
| Normal-vs-Obese |
1.16439999864326E-08 |
| Normal-vs-Extreme_Obese |
4.54800000004862E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.024200E-02 |
| Normal_Weight-vs-Obese |
3.738800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.645400E-01 |
| Extreme_Weight-vs-Obese |
4.864300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.283400E-01 |
| Obese-vs-Extreme_Obese |
6.829200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.441300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.88979951079682E-10 |
| Normal-vs-Age(61-80Yrs) |
6.40509867366745E-12 |
| Normal-vs-Age(81-100Yrs) |
2.6995000002028E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.143400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.095000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.270800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.736000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.178600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.454800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.91491267287347E-12 |
| Normal-VS-Type2 PRCC |
1.643260E-03 |
| Normal-VS-KIRP CIMP |
6.06419999993335E-07 |
| Normal-VS-Unclassified PRCC |
8.6480000005551E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.216540E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.207200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.617000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.806100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.880000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.446820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.28610000216645E-09 |
| Normal-vs-N1 |
3.435500E-02 |
| Normal-vs-N2 |
6.25839999999211E-05 |
| N0-vs-N1 |
4.227700E-02 |
| N0-vs-N2 |
5.042100E-02 |
| N1-vs-N2 |
2.502700E-03 |
|
|
